Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

NeuroSearch Says Huntexil Results Support Individual Trials

Dec. 30 (Bloomberg) -- NeuroSearch A/S said the results of a meta-analysis with its Huntexil treatment for Huntington’s disease support the conclusions drawn from each individual trial, with better precision due to the larger number of observations.

NeuroSearch now plans to present and discuss the Huntexil data with regulators during the first half of 2011.

Link to Statement:{NSN LE8FFJ3HHEDC <GO>}

Link to Company News:{NEUR DC <Equity> CN <GO>}

To contact the editor responsible for this story: Christian Wienberg at cwienberg@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.